NCT04371133View on ClinicalTrials.gov

Anti-inflammatory Markers in Endometrioma

CompletedOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

August 15, 2018

Primary Completion Date

February 15, 2020

Study Completion Date

March 15, 2020

Conditions
EndometriomaInflammation
Interventions
DIAGNOSTIC_TEST

Adropin (ng/L)

Thawed samples were measured on a Molecular Devices SpectraMax i3 Multi-Mode, Microplate Reader (batch number: SER 35 370-1448, made in Austria) using enzyme linked immunosorbent assay (ELISA).

Trial Locations (1)

48000

Mugla Sıtkı Kocman University Faculty of Medicine, Muğla

All Listed Sponsors
lead

Muğla Sıtkı Koçman University

OTHER

NCT04371133 - Anti-inflammatory Markers in Endometrioma | Biotech Hunter | Biotech Hunter